nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—Lamivudine—acquired immunodeficiency syndrome	0.0955	0.124	CbGbCtD
Gadoxetate—ABCC4—Zidovudine—acquired immunodeficiency syndrome	0.0943	0.122	CbGbCtD
Gadoxetate—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0759	0.0982	CbGbCtD
Gadoxetate—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.0736	0.0953	CbGbCtD
Gadoxetate—ABCC4—Lamivudine—acquired immunodeficiency syndrome	0.073	0.0944	CbGbCtD
Gadoxetate—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0667	0.0863	CbGbCtD
Gadoxetate—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.0666	0.0862	CbGbCtD
Gadoxetate—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.0666	0.0862	CbGbCtD
Gadoxetate—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0585	0.0757	CbGbCtD
Gadoxetate—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0585	0.0757	CbGbCtD
Gadoxetate—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0434	0.0562	CbGbCtD
Gadoxetate—Gadofosveset trisodium—ALB—acquired immunodeficiency syndrome	0.00315	1	CrCbGaD
Gadoxetate—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.0026	0.108	CbGeAlD
Gadoxetate—ABCC3—blood plasma—acquired immunodeficiency syndrome	0.00247	0.102	CbGeAlD
Gadoxetate—ABCC4—blood plasma—acquired immunodeficiency syndrome	0.00204	0.0844	CbGeAlD
Gadoxetate—SLCO1B3—vagina—acquired immunodeficiency syndrome	0.00153	0.0633	CbGeAlD
Gadoxetate—SLCO1B3—lung—acquired immunodeficiency syndrome	0.00145	0.0598	CbGeAlD
Gadoxetate—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.001	0.0414	CbGeAlD
Gadoxetate—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000954	0.0395	CbGeAlD
Gadoxetate—ABCC3—digestive system—acquired immunodeficiency syndrome	0.00095	0.0393	CbGeAlD
Gadoxetate—ABCC3—blood—acquired immunodeficiency syndrome	0.000905	0.0374	CbGeAlD
Gadoxetate—ABCC3—lung—acquired immunodeficiency syndrome	0.000793	0.0328	CbGeAlD
Gadoxetate—ABCC4—digestive system—acquired immunodeficiency syndrome	0.000784	0.0324	CbGeAlD
Gadoxetate—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000759	0.0314	CbGeAlD
Gadoxetate—ABCC4—blood—acquired immunodeficiency syndrome	0.000747	0.0309	CbGeAlD
Gadoxetate—ABCC3—nervous system—acquired immunodeficiency syndrome	0.000735	0.0304	CbGeAlD
Gadoxetate—ABCC2—blood—acquired immunodeficiency syndrome	0.000723	0.0299	CbGeAlD
Gadoxetate—ABCC4—bone marrow—acquired immunodeficiency syndrome	0.000723	0.0299	CbGeAlD
Gadoxetate—ABCC3—central nervous system—acquired immunodeficiency syndrome	0.000707	0.0293	CbGeAlD
Gadoxetate—ABCC4—lung—acquired immunodeficiency syndrome	0.000655	0.0271	CbGeAlD
Gadoxetate—ABCC4—nervous system—acquired immunodeficiency syndrome	0.000606	0.0251	CbGeAlD
Gadoxetate—ABCC4—central nervous system—acquired immunodeficiency syndrome	0.000584	0.0242	CbGeAlD
Gadoxetate—ABCC3—brain—acquired immunodeficiency syndrome	0.000562	0.0232	CbGeAlD
Gadoxetate—ABCC3—lymph node—acquired immunodeficiency syndrome	0.000543	0.0225	CbGeAlD
Gadoxetate—ABCC4—brain—acquired immunodeficiency syndrome	0.000464	0.0192	CbGeAlD
Gadoxetate—ABCC4—lymph node—acquired immunodeficiency syndrome	0.000448	0.0185	CbGeAlD
Gadoxetate—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000434	0.0179	CbGeAlD
Gadoxetate—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000215	0.00107	CcSEcCtD
Gadoxetate—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.00107	CcSEcCtD
Gadoxetate—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000214	0.00107	CcSEcCtD
Gadoxetate—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000213	0.00107	CcSEcCtD
Gadoxetate—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.00107	CcSEcCtD
Gadoxetate—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.00107	CcSEcCtD
Gadoxetate—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.00106	CcSEcCtD
Gadoxetate—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.00106	CcSEcCtD
Gadoxetate—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.00106	CcSEcCtD
Gadoxetate—Rash—Didanosine—acquired immunodeficiency syndrome	0.000212	0.00106	CcSEcCtD
Gadoxetate—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.00106	CcSEcCtD
Gadoxetate—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000212	0.00106	CcSEcCtD
Gadoxetate—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000211	0.00106	CcSEcCtD
Gadoxetate—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000211	0.00106	CcSEcCtD
Gadoxetate—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00105	CcSEcCtD
Gadoxetate—Headache—Didanosine—acquired immunodeficiency syndrome	0.00021	0.00105	CcSEcCtD
Gadoxetate—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00021	0.00105	CcSEcCtD
Gadoxetate—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00021	0.00105	CcSEcCtD
Gadoxetate—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000209	0.00105	CcSEcCtD
Gadoxetate—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.00105	CcSEcCtD
Gadoxetate—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000209	0.00105	CcSEcCtD
Gadoxetate—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00105	CcSEcCtD
Gadoxetate—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000209	0.00104	CcSEcCtD
Gadoxetate—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.00104	CcSEcCtD
Gadoxetate—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.00104	CcSEcCtD
Gadoxetate—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.00104	CcSEcCtD
Gadoxetate—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.00104	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000207	0.00104	CcSEcCtD
Gadoxetate—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.00103	CcSEcCtD
Gadoxetate—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000207	0.00103	CcSEcCtD
Gadoxetate—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000206	0.00103	CcSEcCtD
Gadoxetate—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000206	0.00103	CcSEcCtD
Gadoxetate—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000206	0.00103	CcSEcCtD
Gadoxetate—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000206	0.00103	CcSEcCtD
Gadoxetate—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.00103	CcSEcCtD
Gadoxetate—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.00103	CcSEcCtD
Gadoxetate—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000205	0.00102	CcSEcCtD
Gadoxetate—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.00102	CcSEcCtD
Gadoxetate—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.00102	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.00102	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000203	0.00102	CcSEcCtD
Gadoxetate—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000203	0.00102	CcSEcCtD
Gadoxetate—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000203	0.00102	CcSEcCtD
Gadoxetate—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.00101	CcSEcCtD
Gadoxetate—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.00101	CcSEcCtD
Gadoxetate—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.00101	CcSEcCtD
Gadoxetate—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000201	0.00101	CcSEcCtD
Gadoxetate—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000201	0.00101	CcSEcCtD
Gadoxetate—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.00101	CcSEcCtD
Gadoxetate—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.001	CcSEcCtD
Gadoxetate—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.0002	0.001	CcSEcCtD
Gadoxetate—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.0002	0.001	CcSEcCtD
Gadoxetate—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.0002	0.001	CcSEcCtD
Gadoxetate—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000999	CcSEcCtD
Gadoxetate—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000999	CcSEcCtD
Gadoxetate—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000199	0.000997	CcSEcCtD
Gadoxetate—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000199	0.000997	CcSEcCtD
Gadoxetate—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000995	CcSEcCtD
Gadoxetate—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000995	CcSEcCtD
Gadoxetate—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000993	CcSEcCtD
Gadoxetate—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.000992	CcSEcCtD
Gadoxetate—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000988	CcSEcCtD
Gadoxetate—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.000985	CcSEcCtD
Gadoxetate—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000984	CcSEcCtD
Gadoxetate—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000196	0.000982	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000982	CcSEcCtD
Gadoxetate—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.000977	CcSEcCtD
Gadoxetate—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.000973	CcSEcCtD
Gadoxetate—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000194	0.00097	CcSEcCtD
Gadoxetate—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000968	CcSEcCtD
Gadoxetate—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000193	0.000967	CcSEcCtD
Gadoxetate—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000967	CcSEcCtD
Gadoxetate—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000966	CcSEcCtD
Gadoxetate—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000193	0.000966	CcSEcCtD
Gadoxetate—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000965	CcSEcCtD
Gadoxetate—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000193	0.000963	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000193	0.000963	CcSEcCtD
Gadoxetate—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000961	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000192	0.000961	CcSEcCtD
Gadoxetate—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.00096	CcSEcCtD
Gadoxetate—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000192	0.000959	CcSEcCtD
Gadoxetate—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000192	0.000959	CcSEcCtD
Gadoxetate—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.000956	CcSEcCtD
Gadoxetate—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000956	CcSEcCtD
Gadoxetate—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.000952	CcSEcCtD
Gadoxetate—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.000951	CcSEcCtD
Gadoxetate—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00019	0.000951	CcSEcCtD
Gadoxetate—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00019	0.00095	CcSEcCtD
Gadoxetate—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000949	CcSEcCtD
Gadoxetate—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00019	0.000949	CcSEcCtD
Gadoxetate—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000947	CcSEcCtD
Gadoxetate—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000189	0.000945	CcSEcCtD
Gadoxetate—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000943	CcSEcCtD
Gadoxetate—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000941	CcSEcCtD
Gadoxetate—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.00094	CcSEcCtD
Gadoxetate—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000938	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000936	CcSEcCtD
Gadoxetate—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000187	0.000935	CcSEcCtD
Gadoxetate—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000932	CcSEcCtD
Gadoxetate—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.000932	CcSEcCtD
Gadoxetate—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000186	0.000931	CcSEcCtD
Gadoxetate—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000186	0.000931	CcSEcCtD
Gadoxetate—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000929	CcSEcCtD
Gadoxetate—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000186	0.000929	CcSEcCtD
Gadoxetate—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000185	0.000926	CcSEcCtD
Gadoxetate—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.000925	CcSEcCtD
Gadoxetate—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000922	CcSEcCtD
Gadoxetate—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000184	0.000921	CcSEcCtD
Gadoxetate—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000184	0.00092	CcSEcCtD
Gadoxetate—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.00092	CcSEcCtD
Gadoxetate—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.00092	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000184	0.000919	CcSEcCtD
Gadoxetate—Rash—Stavudine—acquired immunodeficiency syndrome	0.000184	0.000919	CcSEcCtD
Gadoxetate—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000184	0.000918	CcSEcCtD
Gadoxetate—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000184	0.000918	CcSEcCtD
Gadoxetate—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000183	0.000917	CcSEcCtD
Gadoxetate—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000916	CcSEcCtD
Gadoxetate—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000183	0.000915	CcSEcCtD
Gadoxetate—Headache—Stavudine—acquired immunodeficiency syndrome	0.000183	0.000913	CcSEcCtD
Gadoxetate—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000183	0.000912	CcSEcCtD
Gadoxetate—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.00091	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.00091	CcSEcCtD
Gadoxetate—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000182	0.000908	CcSEcCtD
Gadoxetate—Rash—Abacavir—acquired immunodeficiency syndrome	0.000181	0.000905	CcSEcCtD
Gadoxetate—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000181	0.000904	CcSEcCtD
Gadoxetate—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000904	CcSEcCtD
Gadoxetate—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000904	CcSEcCtD
Gadoxetate—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000903	CcSEcCtD
Gadoxetate—Headache—Abacavir—acquired immunodeficiency syndrome	0.00018	0.000899	CcSEcCtD
Gadoxetate—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.000898	CcSEcCtD
Gadoxetate—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000179	0.000896	CcSEcCtD
Gadoxetate—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000179	0.000896	CcSEcCtD
Gadoxetate—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000889	CcSEcCtD
Gadoxetate—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000886	CcSEcCtD
Gadoxetate—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000885	CcSEcCtD
Gadoxetate—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000884	CcSEcCtD
Gadoxetate—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.000884	CcSEcCtD
Gadoxetate—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.00088	CcSEcCtD
Gadoxetate—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.00088	CcSEcCtD
Gadoxetate—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000878	CcSEcCtD
Gadoxetate—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000878	CcSEcCtD
Gadoxetate—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.000877	CcSEcCtD
Gadoxetate—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.000874	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.00087	CcSEcCtD
Gadoxetate—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000174	0.000868	CcSEcCtD
Gadoxetate—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000174	0.000868	CcSEcCtD
Gadoxetate—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000173	0.000866	CcSEcCtD
Gadoxetate—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000173	0.000865	CcSEcCtD
Gadoxetate—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000862	CcSEcCtD
Gadoxetate—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000856	CcSEcCtD
Gadoxetate—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000171	0.000852	CcSEcCtD
Gadoxetate—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000851	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.00085	CcSEcCtD
Gadoxetate—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000849	CcSEcCtD
Gadoxetate—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.000846	CcSEcCtD
Gadoxetate—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000845	CcSEcCtD
Gadoxetate—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000845	CcSEcCtD
Gadoxetate—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000845	CcSEcCtD
Gadoxetate—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000842	CcSEcCtD
Gadoxetate—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000842	CcSEcCtD
Gadoxetate—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000842	CcSEcCtD
Gadoxetate—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.000837	CcSEcCtD
Gadoxetate—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000167	0.000833	CcSEcCtD
Gadoxetate—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000824	CcSEcCtD
Gadoxetate—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000164	0.00082	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000818	CcSEcCtD
Gadoxetate—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000817	CcSEcCtD
Gadoxetate—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000812	CcSEcCtD
Gadoxetate—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000811	CcSEcCtD
Gadoxetate—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.00081	CcSEcCtD
Gadoxetate—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000806	CcSEcCtD
Gadoxetate—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000161	0.000806	CcSEcCtD
Gadoxetate—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000161	0.000805	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000805	CcSEcCtD
Gadoxetate—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00016	0.000798	CcSEcCtD
Gadoxetate—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000798	CcSEcCtD
Gadoxetate—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00016	0.000798	CcSEcCtD
Gadoxetate—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000159	0.000793	CcSEcCtD
Gadoxetate—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000157	0.000787	CcSEcCtD
Gadoxetate—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000786	CcSEcCtD
Gadoxetate—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000157	0.000784	CcSEcCtD
Gadoxetate—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000782	CcSEcCtD
Gadoxetate—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000781	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.00078	CcSEcCtD
Gadoxetate—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000779	CcSEcCtD
Gadoxetate—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000156	0.000779	CcSEcCtD
Gadoxetate—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000778	CcSEcCtD
Gadoxetate—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000778	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000775	CcSEcCtD
Gadoxetate—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000773	CcSEcCtD
Gadoxetate—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000764	CcSEcCtD
Gadoxetate—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000761	CcSEcCtD
Gadoxetate—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000753	CcSEcCtD
Gadoxetate—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000753	CcSEcCtD
Gadoxetate—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00015	0.000752	CcSEcCtD
Gadoxetate—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000749	CcSEcCtD
Gadoxetate—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000749	CcSEcCtD
Gadoxetate—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000749	CcSEcCtD
Gadoxetate—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000745	CcSEcCtD
Gadoxetate—Rash—Indinavir—acquired immunodeficiency syndrome	0.000149	0.000742	CcSEcCtD
Gadoxetate—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000742	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000739	CcSEcCtD
Gadoxetate—Headache—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000738	CcSEcCtD
Gadoxetate—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.000736	CcSEcCtD
Gadoxetate—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000728	CcSEcCtD
Gadoxetate—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000725	CcSEcCtD
Gadoxetate—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000718	CcSEcCtD
Gadoxetate—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000715	CcSEcCtD
Gadoxetate—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000715	CcSEcCtD
Gadoxetate—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000707	CcSEcCtD
Gadoxetate—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000706	CcSEcCtD
Gadoxetate—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000704	CcSEcCtD
Gadoxetate—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.000701	CcSEcCtD
Gadoxetate—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.000701	CcSEcCtD
Gadoxetate—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000699	CcSEcCtD
Gadoxetate—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000698	CcSEcCtD
Gadoxetate—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000697	CcSEcCtD
Gadoxetate—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000696	CcSEcCtD
Gadoxetate—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.00068	CcSEcCtD
Gadoxetate—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000677	CcSEcCtD
Gadoxetate—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000674	CcSEcCtD
Gadoxetate—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000671	CcSEcCtD
Gadoxetate—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000671	CcSEcCtD
Gadoxetate—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.00067	CcSEcCtD
Gadoxetate—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000667	CcSEcCtD
Gadoxetate—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000666	CcSEcCtD
Gadoxetate—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000661	CcSEcCtD
Gadoxetate—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000651	CcSEcCtD
Gadoxetate—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000649	CcSEcCtD
Gadoxetate—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000648	CcSEcCtD
Gadoxetate—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000639	CcSEcCtD
Gadoxetate—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000632	CcSEcCtD
Gadoxetate—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000627	CcSEcCtD
Gadoxetate—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000626	CcSEcCtD
Gadoxetate—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000621	CcSEcCtD
Gadoxetate—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.00062	CcSEcCtD
Gadoxetate—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000618	CcSEcCtD
Gadoxetate—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000617	CcSEcCtD
Gadoxetate—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000602	CcSEcCtD
Gadoxetate—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000598	CcSEcCtD
Gadoxetate—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000597	CcSEcCtD
Gadoxetate—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000597	CcSEcCtD
Gadoxetate—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000594	CcSEcCtD
Gadoxetate—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000585	CcSEcCtD
Gadoxetate—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000575	CcSEcCtD
Gadoxetate—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.00057	CcSEcCtD
Gadoxetate—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000569	CcSEcCtD
Gadoxetate—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000566	CcSEcCtD
Gadoxetate—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000563	CcSEcCtD
Gadoxetate—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000537	CcSEcCtD
